Publications by authors named "Colin Garner"

Claim this Profile
C
Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use.
Yanhong Jessika Hu, Xudong Zhou, Shanjuan Wang, Merlin Willcox, Colin Garner

Pilot Feasibility Stud· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deviations from classical droplet evaporation theory.
Joshua Finneran, Colin P Garner, François Nadal

Proc Math Phys Eng Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diarrhoea Management using Over-the-counter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use.
Yanhong Jessika Hu, Xudong Zhou, Shanjuan Wang, Merlin Willcox, Colin Garner

Pilot Feasibility Stud· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-linearity of the pharmacokinetics of an intravenous [ C]midazolam microdose in children.
Bianca D van Groen, Wouter H Vaes, B Kevin Park, Elke H J Krekels, Esther van Duijn, R Colin Garner

Br J Clin Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative Pathogens.
Charlotte K Hind, Christopher G Dowson, J Mark Sutton, Thomas Jackson, Melanie Clifford, R Colin Garner

Antimicrob Agents Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal conductivity and molecular heat transport of nanofluids.
Nader Dolatabadi, Ramin Rahmani, Homer Rahnejat, Colin P Garner

RSC Adv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ask the experts: how to curb antibiotic resistance and plug the antibiotics gap?
Laura Piddock, Sylvie Garneau-Tsodikova, Colin Garner

Future Med Chem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.
Colin R Garner, Kevin B Park, Neil S French, Caroline Earnshaw, Alessandro Schipani

Br J Clin Pharmacol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects.
Nachum Kaplan, Colin Garner, Barry Hafkin

Eur J Pharm Sci· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Graham Lappin, Yoko Shishikura, Roeline Jochemsen, Richard John Weaver, Charlotte Gesson, Colin Garner

Eur J Pharm Sci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
Graham Lappin, Yoko Shishikura, Roeline Jochemsen, Richard John Weaver, Charlotte Gesson, Colin Garner

Eur J Pharm Sci· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
R Colin Garner

Bioanalysis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdose pharmacokinetics of IDX899 and IDX989, candidate HIV-1 non-nucleoside reverse transcriptase inhibitors, following oral and intravenous administration in healthy male subjects.
Xiao-Jian Zhou, R Colin Garner, Sheila Nicholson, C James Kissling, Douglas Mayers

J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.
Ajay Madan, Zhihong O'Brien, Jianyun Wen, Chris O'Brien, Robert H Farber, R Colin Garner

Br J Clin Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of microdosing over the past 5 years.
Graham Lappin, R Colin Garner

Expert Opin Drug Metab Toxicol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia.
Alan V Boddy, Julieann Sludden, Melanie J Griffin, Colin Garner, John Kendrick

Clin Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
Graham Lappin, Wilhelm Kuhnz, Roeline Jochemsen, Johannes Kneer, Ajai Chaudhary, R Colin Garner

Clin Pharmacol Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of isotopes in the determination of absolute bioavailability of drugs in humans.
Graham Lappin, Malcolm Rowland, R Colin Garner

Expert Opin Drug Metab Toxicol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phase 0 microdosing concept.
R Colin Garner, Graham Lappin

Br J Clin Pharmacol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of accelerator mass spectrometry to obtain early human ADME/PK data.
Graham Lappin, R Colin Garner

Expert Opin Drug Metab Toxicol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less is more: the human microdosing concept.
R Colin Garner

Drug Discov Today· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer.
Faye Turner, Gillian Smith, Christoph Sachse, Tracy Lightfoot, R Colin Garner

Int J Cancer· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of accelerator mass spectrometry with gas chromatography for the determination of pesticide residues in individual items in the diets of wild birds and mammals.
Peter Brown, Colin Garner, Richard Glass, Chris Ridgway, Andy Hart

J Agric Food Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
Graham Lappin, R Colin Garner

Anal Bioanal Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.
Elizabeth A Martin, Karen Brown, Margaret Gaskell, Farook Al-Azzawi, R Colin Garner

Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis